We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Top-Ranked Healthcare Funds to Buy for Outstanding Returns
Read MoreHide Full Article
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Franklin Biotechnology Discovery Fund primarily invests in biotechnology and discovery research companies, mainly through equities. It may also invest in other issuers’ equity or debt securities and follows a non-diversified strategy.
Franklin Biotechnology Discovery Fund has three-year annualized returns of 26%. As of January 2026, FBDIX held 81 issues, with 6.2% of its assets invested in Gilead Sciences.
Fidelity Select Pharmaceuticals Portfolio primarily invests in pharmaceutical and drug-related companies worldwide, mainly through common stocks. Investment selection is based on fundamental analysis of company, industry, market and economic factors. It is non-diversified.
Fidelity Select Pharmaceuticals Portfolio has three-year annualized returns of 18.5%. FPHAX has an expense ratio of 0.67%.
Fidelity Select Biotechnology Portfolio primarily invests in common stocks of biotechnology companies worldwide, focusing on firms advancing or benefiting from biotechnology innovation. Investments are selected through fundamental analysis of company, industry, market and economic factors. It is non-diversified.
Fidelity Select Biotechnology Portfolio has three-year annualized returns of 18.9%. Rajiv Kaul has been the fund manager of FBIOX since October 2005.
View the Zacks #1 Rank List
Image: Bigstock
3 Top-Ranked Healthcare Funds to Buy for Outstanding Returns
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below, we share with you three top-ranked Healthcare mutual funds, namely Franklin Biotechnology Discovery Fund (FBDIX - Free Report) , Fidelity Select Pharmaceuticals Portfolio (FPHAX - Free Report) and Fidelity Select Biotechnology Portfolio (FBIOX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Franklin Biotechnology Discovery Fund primarily invests in biotechnology and discovery research companies, mainly through equities. It may also invest in other issuers’ equity or debt securities and follows a non-diversified strategy.
Franklin Biotechnology Discovery Fund has three-year annualized returns of 26%. As of January 2026, FBDIX held 81 issues, with 6.2% of its assets invested in Gilead Sciences.
Fidelity Select Pharmaceuticals Portfolio primarily invests in pharmaceutical and drug-related companies worldwide, mainly through common stocks. Investment selection is based on fundamental analysis of company, industry, market and economic factors. It is non-diversified.
Fidelity Select Pharmaceuticals Portfolio has three-year annualized returns of 18.5%. FPHAX has an expense ratio of 0.67%.
Fidelity Select Biotechnology Portfolio primarily invests in common stocks of biotechnology companies worldwide, focusing on firms advancing or benefiting from biotechnology innovation. Investments are selected through fundamental analysis of company, industry, market and economic factors. It is non-diversified.
Fidelity Select Biotechnology Portfolio has three-year annualized returns of 18.9%. Rajiv Kaul has been the fund manager of FBIOX since October 2005.
To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>